We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Specialist Shortages Could Affect European Medical Oncology

By HospiMedica International staff writers
Posted on 22 Oct 2013
The European Society for Medical Oncology (ESMO; Lugano, Switzerland) warns that many European countries may face a future shortage of medical oncologists without realizing it, a situation that could have dire consequences for cancer patients.

ESMO researchers reviewed data regarding the projected number of medical oncologists in Europe and tried to predict if European countries will face a shortage of medical oncologists by 2020; adequate data was only available, however, for 12 of 27 European Union nations. When looking at the available data, the researchers concluded that there will not be any shortage of medical oncologists in Central European and Western European countries by 2020, but the data was not available for several countries with large populations, including the Russian Federation, Turkey, Spain, Poland, and Greece.

The researchers warned, however, that the data is based on cancer incidence and not cancer prevalence; furthermore, the current economic crisis might have an influence on the number of doctors and specialists migrating to other countries. Additionally, the data indicates that the number of people who develop cancers in greater Europe is expected to grow to 3.4 million each year by 2020, representing a 20% increase from 2002.

ESMO believes that continuous monitoring from official authorities is the only way to ensure that the ratio of new cases of cancer to medical oncologists is adequate, allowing specialist-training programs to be modified and new posts for medical oncologists created to maintain adequate numbers. The review was presented at the European Cancer Congress, held during September 2013 in Amsterdam (The Netherlands).

“We believe the next step is to endeavor to collect data from the nonsurveyed countries in order to have definitive information about the expected change in number of medical oncologists across all EU countries,” said consultant medical oncologist Raffaele Califano, MD, chair of the ESMO Young Oncologists Committee. “This will help to understand fully if Europe is ready to face the new cancer cases predicted by 2020 and appropriate resources are in place.”

Related Links:

European Society for Medical Oncology




Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Cannulating Sphincterotome
TRUEtome
New
Computed Tomography System
Aquilion ONE / INSIGHT Edition

Latest Business News

MEDICA 2024 to Highlight Hot Topics of MedTech Industry

Start-Ups To Once Again Play Starring Role at MEDICA 2024

Boston Scientific to Acquire AFib Ablation Company Cortex